EQL Pharma AB (FRA:7JK) Net Change in Cash : €-1.01 Mil (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is EQL Pharma AB Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

EQL Pharma AB's Net Change in Cash for the three months ended in Jun. 2024 was €-0.63 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 was €-1.01 Mil.

EQL Pharma AB Net Change in Cash Historical Data

The historical data trend for EQL Pharma AB's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Net Change in Cash Chart

EQL Pharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Change in Cash

Get a 7-Day Free Trial

-1.05

1.60

1.39

0.29

-2.12

EQL Pharma AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Net Change in Cash	Get a 7-Day Free Trial															-1.68	-0.33	-0.93	0.89	-0.63

EQL Pharma AB Net Change in Cash Calculation

EQL Pharma AB's Net Change in Cash for the fiscal year that ended in Mar. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-1.011	+	-5.855	+	4.749	+	0
	=	-2.12

EQL Pharma AB's Net Change in Cash for the quarter that ended in Jun. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -1.751 + -0.681 + 1.804 + 0

= -0.63

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EQL Pharma AB Net Change in Cash Related Terms
Thank you for viewing the detailed overview of EQL Pharma AB's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

EQL Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (FRA:7JK) » Definitions » Net Change in Cash

Comparable Companies

OSTO:ENZY OSTO:ORX OSTO:CRNO B OSTO:ALZCUR OSTO:MOB OSTO:ERMA OSTO:VIVE XSAT:PMED XSAT:ODI XSAT:DICOT ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Traded in Other Exchanges

EQL:Sweden

Address

Stortorget 1, 3rd Floor, Lund, SWE, 222 23

Website

http://www.eqlpharma.com

EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB Headlines

No Headlines